Emyria Expands National Reach with First Victorian Empax Clinic
Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.
- First Empax clinic secured in Victoria at Mornington Peninsula
- National clinic platform now spans Western Australia, Queensland, and Victoria
- Capital-light, hospital-integrated operating model proven across states
- Reimbursement pathways active ahead of clinic openings to support revenue
- Recruitment of psychiatrists and therapists underway for Victorian clinic
A Milestone in Multi-State Expansion
Emyria Limited (ASX – EMD) has announced a pivotal development in its national mental health strategy by securing its first Empax clinic in Victoria, located at the Mornington Peninsula. This achievement completes the company’s initial multi-state footprint, complementing existing clinics in Western Australia and Queensland. The Victorian clinic is set to operate within Avive Health’s flagship mental health hospital, marking a key East Coast expansion milestone for Emyria.
With this move, Emyria transitions from establishing individual clinics to operating a scalable national platform. The company’s approach leverages a capital-light, hospital-integrated model that reduces upfront costs and accelerates clinic activation, a strategy that has already proven successful in other states.
Validated Operating Model and Revenue Pathways
Emyria’s Empax clinics are embedded within existing licensed hospital environments, enabling streamlined integration with hospital workflows and established reimbursement frameworks. This integration is critical, as it supports insurer-funded revenue streams that activate as new clinics come online. The Victorian clinic’s licensing agreement with Avive Health includes exclusivity provisions and a fee structure designed to grow over time, underscoring the commercial viability of the model.
Importantly, reimbursement pathways are already active in the states where clinics operate or are secured, providing a foundation for revenue growth as patient throughput increases. This reimbursed revenue model positions Emyria to deliver operating leverage as it scales its clinic network nationally.
Recruitment and Growth Outlook
Preparations for the Victorian clinic are well underway, with recruitment of therapists and psychiatrists commencing immediately. Two psychiatrist Authorised Prescriber applications are already in progress, reflecting the company’s commitment to clinical excellence and regulatory compliance. The clinic is expected to begin treating patients in the second quarter of 2026, following regulatory approvals and facility fit-out.
Looking ahead, Emyria plans to continue its disciplined, hospital-led expansion across Australia. The company aims to increase patient capacity, expand its clinical workforce, and drive operating efficiencies within its capital-light framework. Each new clinic not only broadens geographic reach but also enhances the economics of the national platform.
Strategic Implications
Executive Chairman Greg Hutchinson highlighted the significance of this milestone, emphasizing that the Victorian clinic strengthens Emyria’s network and validates its multi-state deployment strategy. The company’s ability to replicate its model consistently across jurisdictions reduces execution risk and provides a clear pathway for growth in insurer-funded mental health services.
As mental health care evolves, Emyria’s integrated approach combining clinical services with innovative therapies positions it well to capture emerging opportunities. The company’s focus on evidence-based intensive care and reimbursement-aligned expansion could set a benchmark for scalable mental health treatment delivery in Australia.
Bottom Line?
Emyria’s Victorian clinic launch signals a new phase of national growth, with insurer-funded mental health care poised for broader impact.
Questions in the middle?
- How quickly will the Victorian clinic ramp up patient numbers to reach steady-state operations?
- What are the prospects for expanding Empax clinics beyond the current three states?
- How will regulatory approvals and reimbursement changes affect Emyria’s growth trajectory?
